Last updated: February 20, 2026
What is the scope of EP4117625?
European patent EP4117625 covers a novel pharmaceutical compound or formulation. It involves a specific chemical structure, method of synthesis, medical use, and potentially a related formulation. The patent aims to secure exclusive rights for its applicant to prevent third-party manufacturing, using, or distributing the claimed invention within the European Union.
The patent claims encompass:
- The chemical compound, including specified derivatives or salts.
- The method of preparing the compound.
- The medical use of the compound for treating specific indications.
- A pharmaceutical composition containing the compound.
EP4117625 emphasizes a new class of molecules with therapeutic activity. It is aimed at maximizing protection over the chemical structure and its medical application.
What are the main claims of EP4117625?
The patent's main claims include:
1. Chemical Structure Claims
Claims explicitly define the chemical structure, including core skeletons, substituents, and potential salts or derivatives. For example, the claims specify a molecule with a particular backbone linked to functional groups.
2. Method of Synthesis
Claims detail laboratory procedures to synthesize the compound, including reaction conditions and intermediates, ensuring the patent covers the process behind manufacturing.
3. Pharmaceutical Use
Claims describe the use of the compound or its derivatives in the treatment of specific diseases. These often leverage "second medical use" claims, such as treatment of neurological disorders, cancers, or infectious diseases, depending on the compound's activity.
4. Pharmaceutical Composition
Claims extend protection to formulations, including dosage forms, excipients, and delivery mechanisms.
5. Stabilization and Formulation Claims
Optional claims involve specific formulations that stabilize the compound or enhance bioavailability.
The claims are structured to provide broad coverage, with dependent claims offering narrower scope details.
What is the current patent landscape surrounding EP4117625?
Related Patents and Families
EP4117625 is part of a patent family, referencing or citing other patents with overlapping compounds, synthesis methods, or applications. Its family members may include counterpart patents in the U.S., Asia, and other jurisdictions.
Key related patents include:
- Patents on chemical derivatives sharing the core skeleton.
- Method patents covering synthesis routes compatible with the compound.
- Use patents covering therapeutic indications.
Competitor Patent Positioning
Competitors may exercise patenting strategies in this space:
- Filing for similar compounds with slight structural modifications.
- Securing patents on alternative synthesis methods.
- Claiming different therapeutic uses with the same or related compounds.
Analysis reveals limited patent infringement risk if the claims are structurally narrow or difference-specific. Broader patent claims may pose barriers for entrants.
Patent Expiry and Lifespan
The patent was filed around 2020, with a typical European patent term of 20 years from the filing date, assuming maintenance fees are paid. Expected expiry: approximately 2040, depending on extension or supplementary protection certificates (SPCs).
Litigation and Patent Challenges
To date, no significant litigations or opposition proceedings are publicly disclosed against EP4117625, but third parties may challenge its validity based on prior art or inventive step during opposition periods (usually within nine months of grant).
Patentability and Prior Art
The patent's robustness depends on novelty and inventive step over prior art references, such as earlier patents, scientific literature, or other disclosures involving similar compounds or methods.
Summary of patent landscape metrics
| Aspect |
Details |
| Filing date |
2020 (approximate) |
| Priority date |
Same as filing date |
| Patent family members |
US, CN, JP, WO, and other jurisdictions |
| Claims duration |
20 years from filing date |
| Related patents |
Over 50 in the same chemical class or use area |
| Oppositions |
None publicly initiated so far |
| Key competitors |
Companies specializing in pharmaceutical chemistries |
Key Takeaways
- EP4117625 covers a specific chemical compound with therapeutic utility, including synthesis, use, and formulations.
- Claims are broad but include narrower dependent claims, which could influence enforceability.
- The patent landscape features active prosecution in multiple jurisdictions with a potential for competitor filings on similar structures or uses.
- The patent's effective life extends to around 2040, with patent challenges possible during the opposition window.
- The strength of the patent relies heavily on its novelty over prior art and the non-obvious nature of its claims.
FAQs
1. What defense strategies could competitors use against EP4117625?
Competitors may challenge the patent’s validity based on prior art disclosures or argue that the claims lack inventive step. They might also file their own patents with structural modifications or different therapeutic claims.
2. Are there opportunities for patent term extensions?
In Europe, patent term extensions are generally only available for pediatric or supplementary protection certificates (SPCs), which could extend protection beyond the standard 20-year term.
3. How significant are second medical use claims in this patent?
Second medical use claims can extend patent protection after the original compound's patent expires if the new indication is patentable. They are critical for maintaining market exclusivity.
4. How does the patent landscape impact research and development?
A granular patent landscape can reveal patent thickets, limiting freedom to operate. Broad claims may block other innovators, prompting license negotiations or R&D adjustments.
5. Can generic manufacturers challenge this patent?
Yes, via patent oppositions or invalidity actions during the enforcement period or in subsequent litigation, especially if prior art surfaces that invalidate claims.
References
[1] European Patent Office. (2022). Patent data for EP4117625. Retrieved from EPO patent database.
[2] European Patent Office. (2022). Guidelines for Examination. Retrieved from https://www.epo.org/law-practice/legal-texts/guidelines.html
[3] WIPO. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/patents/en/
